Akeso Biopharma

Akeso Biopharma is a leading pharmaceutical manufacturing company dedicated to integrating superior global resources to develop first-in-class and best-in-class new drugs. With a commitment to providing affordable therapeutic antibodies for patients worldwide, Akeso Biopharma continuously creates commercial and social value to become a globally recognized biopharmaceutical enterprise. The primary address of Akeso Biopharma is 神农路6号, 中山, 广东, CN. Additional locations include 黄埔区中新知识城康耀南路158号, 广州, 广东, CN; 黄埔区科学城科学大道162号创意大厦B2栋1101, 广州, 广东, CN; 北京市朝阳区广渠路66号院22号楼18层, 北京, 北京市, CN; 上海市徐汇区枫林路380号枫林大厦, 上海, 上海市, CN; 南通市崇川区星城路299号5号楼502室, 南通, 江苏, CN; 湾仔港湾道18号中环广场43楼4308室, 香港, HK; 48521 Warm Springs Blvd, Suite 311, 弗里蒙特, 加利福尼亚州 94539, US; and Floor 17, HWT Tower, 40 City Road, Southbank, Victoria, 3006, Southbank VIC 3006, AU. Founded in 2012, Akeso Biopharma operates with a fully integrated multi-functional platform, supporting a robust pipeline of innovative assets.

Akeso Biopharma is focused on advancing healthcare through cutting-edge research and development in areas such as cancer, autoimmune diseases, inflammation, metabolic diseases, and other major health challenges. Akeso currently has multiple candidates in clinical trials, including bispecific and multispecific antibodies and antibody-drug conjugates, with several new drugs commercially available and under regulatory review. Akeso Biopharma's commitment to innovation and patient care drives its mission to deliver impactful therapies to those in need.

Akeso Biopharma's strategic vision and dedication to excellence position it as a key player in the global biopharmaceutical landscape. Akeso continues to expand its reach and impact, striving to meet the evolving needs of patients and healthcare providers worldwide. We invite the manager of Akeso Biopharma to create a customized and exclusive company showcase and product listing on our platform to further enhance your visibility and commercial opportunities.